Identification and Evaluation of New Potential Inhibitors of Human Neuraminidase 1 Extracted from <i>Olyra latifolia</i> L.: A Preliminary Study
Sialidases, also called neuraminidases, are involved in several human pathologies such as neurodegenerative disorders, cancers, as well as infectious and cardiovascular diseases. Several studies have shown that neuraminidases, such as neuraminidase 1 (NEU-1), may be promising pharmacological targets...
Main Authors: | Camille Albrecht, Zachée Louis Evariste Akissi, Philomène Akoua Yao-Kouassi, Abdulmagid Alabdul Magid, Pascal Maurice, Laurent Duca, Laurence Voutquenne-Nazabadioko, Amar Bennasroune |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/4/411 |
Similar Items
-
Antibody against Microbial Neuraminidases Recognizes Human Sialidase 3 (NEU3): the Neuraminidase/Sialidase Superfamily Revisited
by: Chiguang Feng, et al.
Published: (2017-07-01) -
Inhibitors of Human Neuraminidase Enzymes Block Transmigration in vitro
by: Md. Amran Howlader, et al.
Published: (2022-02-01) -
Transmembrane Peptides as a New Strategy to Inhibit Neuraminidase-1 Activation
by: Camille Albrecht, et al.
Published: (2020-12-01) -
Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors
by: Tanguy Eveno, et al.
Published: (2019-05-01) -
Inhibition of sialidase activity as a therapeutic approach
by: Glanz VY, et al.
Published: (2018-10-01)